– a generally known phenomenon? This is probably because it is being referenced more and more in policy (and funding related) documents and this is because multimorbidity is identified as a cause of increased health care costs.
A few decades ago, chronic diseases began to assume importance as they became relatively more common when compared to acute illnesses and as infectious diseases have become more treatable. Co-morbidities then began to be mentioned in specialist clinics where it was noted that, for instance, patients with COPD might also have cardiac or peripheral vascular disease – and that these co-morbidities and their treatments might impact on the disease under care.
This was a rather specialist view. In the Geriatric
In
The American Geriatric Society has produced a handy Pocketcard summary of their guidelines.
In the UK, Multimorbidity guidelines have been produced
Minimally Disruptive Medicine: Is healthcare careful? Is it kind?
MedEdPurls has three posts on Teaching Multimorbidity:
http://mededpurls.com/blog/index.php/2016/10/31/teaching-multimorbidity-part-one/
http://mededpurls.com/blog/index.php/2016/11/05/teaching-multimorbidity-part-two/
http://mededpurls.com/blog/index.php/2016/11/13/teaching-multimorbidity-part-three/
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreGenetic testing in general practice: Dr. Alan Ma explains which tests GPs can order, when to refer, and how the PRECISE portal supports confident testing and referral decisions.
MyMedicare is now part of routine general practice, with practical implications for billing, continuity of care, and practice systems. This FastTrack clarifies important points regarding eligibility, impacts on the GPCCMP billing, and how to avoid rejected claims. 30mins each RP and EA available.
Genomics is now part of everyday general practice. The PRECISE Genomics in Primary Care hub gives Australian GPs fast, practical tools to recognise genetic red flags, guide testing and support timely referrals.